Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 14 Oct 2026 for MiNK Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleJennifer Buell
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Jennifer Buell: trading record in brief
Jennifer Buell, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Agenus Inc and MiNK Therapeutics, Inc. Over a trading history stretching from 30 June 2021 to 12 October 2026, the count stands at 21 filings.
The open-market record consists of 1 sale worth €65k, with no purchase. Besides market trades, the filings include 17 share grants and 2 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
The record was last updated on 14 October 2026 with an option exercise in MiNK Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jennifer Buell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
23,191 sharesCommon StockSEC:0001193125-26-421529:0
6,938 shares@ US$10.56Common StockSEC:0001193125-26-421529:1
10,024 shares@ US$11.120.18% mcap8.6% of flowCommon StockSEC:0001193125-26-012914:0
31,474 shares@ US$11.1227.0% of flowCommon StockSEC:0001193125-26-004799:0
5,351 shares@ US$15.360.13% mcap6.4% of flowCommon StockSEC:0001193125-25-230098:0
18,229 shares@ US$15.3621.7% of flowCommon StockSEC:0001193125-25-201376:0
581 shares@ US$3.112.4% of flowCommon StockSEC:0000950170-25-064636:0
869 shares@ US$2.082.4% of flowCommon StockSEC:0000950170-25-063522:0
1,159 shares@ US$1.562.5% of flowCommon StockSEC:0000950170-25-052895:0
1,123 shares@ US$1.612.5% of flowCommon StockSEC:0000950170-25-046050:0
409 shares@ US$2.351.4% of flowCommon StockSEC:0000950170-25-043817:0
545 shares@ US$3.322.6% of flowCommon StockSEC:0000950170-25-037127:0
626 shares@ US$3.323.0% of flowCommon StockSEC:0000950170-25-033526:0
516 shares@ US$3.502.7% of flowCommon StockSEC:0000950170-25-022204:0
270 shares@ US$3.571.4% of flowCommon StockSEC:0000950170-25-013409:0
776 shares@ US$3.574.1% of flowCommon StockSEC:0000950170-25-010023:0
695,750 sharesCommon StockSEC:0000950170-23-053381:0
25,000 shares@ US$1.15382.5% of flowCommon StockSEC:0000950170-23-051760:0
695,750 sharesCommon StockSEC:0000950170-23-050807:0
171,990 shares@ US$2.3233.9% of flowCommon StockSEC:0000899243-23-001620:0
10,597 shares@ US$5.4974.9% of flowCommon StockSEC:0000899243-21-027356:0
21 of 21 declarations
